166 related articles for article (PubMed ID: 28792652)
1. Mutations in the novel gene FOPV are associated with familial autosomal dominant and non-familial obliterative portal venopathy.
Besmond C; Valla D; Hubert L; Poirier K; Grosse B; Guettier C; Bernard O; Gonzales E; Jacquemin E
Liver Int; 2018 Feb; 38(2):358-364. PubMed ID: 28792652
[TBL] [Abstract][Full Text] [Related]
2. Obliterative portal venopathy: portal hypertension is not always present at diagnosis.
Cazals-Hatem D; Hillaire S; Rudler M; Plessier A; Paradis V; Condat B; Francoz C; Denninger MH; Durand F; Bedossa P; Valla DC
J Hepatol; 2011 Mar; 54(3):455-61. PubMed ID: 21087805
[TBL] [Abstract][Full Text] [Related]
3. Obliterative portal venopathy without portal hypertension: an underestimated condition.
Guido M; Sarcognato S; Sonzogni A; Lucà MG; Senzolo M; Fagiuoli S; Ferrarese A; Pizzi M; Giacomelli L; Colloredo G
Liver Int; 2016 Mar; 36(3):454-60. PubMed ID: 26264219
[TBL] [Abstract][Full Text] [Related]
4. A de novo mutation in KCNN3 associated with autosomal dominant idiopathic non-cirrhotic portal hypertension.
Koot BG; Alders M; Verheij J; Beuers U; Cobben JM
J Hepatol; 2016 Apr; 64(4):974-7. PubMed ID: 26658685
[TBL] [Abstract][Full Text] [Related]
5. Multimodality imaging of obliterative portal venopathy: what every radiologist should know.
Arora A; Sarin SK
Br J Radiol; 2015 Feb; 88(1046):20140653. PubMed ID: 25514699
[TBL] [Abstract][Full Text] [Related]
6. Obliterative portal venopathy: a clinical and histopathological review.
Aggarwal S; Fiel MI; Schiano TD
Dig Dis Sci; 2013 Oct; 58(10):2767-76. PubMed ID: 23812828
[TBL] [Abstract][Full Text] [Related]
7. Obliterative portal venopathy: findings at CT imaging.
Glatard AS; Hillaire S; d'Assignies G; Cazals-Hatem D; Plessier A; Valla DC; Vilgrain V
Radiology; 2012 Jun; 263(3):741-50. PubMed ID: 22474672
[TBL] [Abstract][Full Text] [Related]
8. Obliterative portal venopathy: a study of 48 children.
Franchi-Abella S; Fabre M; Mselati E; De Marsillac ME; Bayari M; Pariente D; Jacquemin E; Bernard O
J Pediatr; 2014 Jul; 165(1):190-193.e2. PubMed ID: 24768253
[TBL] [Abstract][Full Text] [Related]
9. Aberrant von Willebrand factor expression of sinusoidal endothelial cells and quiescence of hepatic stellate cells in nodular regenerative hyperplasia and obliterative portal venopathy.
Zhang X; Thomas C; Schiano TD; Thung SN; Ward SC; Fiel MI
Histopathology; 2020 Jun; 76(7):959-967. PubMed ID: 31994248
[TBL] [Abstract][Full Text] [Related]
10. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM
Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088
[TBL] [Abstract][Full Text] [Related]
11. Obliterative Portal Venopathy Without Cirrhosis Is Prevalent in Pediatric Cystic Fibrosis Liver Disease With Portal Hypertension.
Wu H; Vu M; Dhingra S; Ackah R; Goss JA; Rana A; Quintanilla N; Patel K; Leung DH
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2134-2136. PubMed ID: 30404037
[TBL] [Abstract][Full Text] [Related]
12. Key histopathologic features in idiopathic noncirrhotic portal hypertension: an interobserver agreement study and proposal for diagnostic criteria.
Liang J; Shi C; Dupont WD; Salaria SN; Huh WJ; Correa H; Roland JT; Perri RE; Washington MK
Mod Pathol; 2021 Mar; 34(3):592-602. PubMed ID: 32958831
[TBL] [Abstract][Full Text] [Related]
13. Pathology of idiopathic non-cirrhotic portal hypertension.
Guido M; Sarcognato S; Sacchi D; Colloredo G
Virchows Arch; 2018 Jul; 473(1):23-31. PubMed ID: 29644430
[TBL] [Abstract][Full Text] [Related]
14. Utilization of Whole Exome Sequencing to Identify Causative Mutations in Familial Congenital Heart Disease.
LaHaye S; Corsmeier D; Basu M; Bowman JL; Fitzgerald-Butt S; Zender G; Bosse K; McBride KL; White P; Garg V
Circ Cardiovasc Genet; 2016 Aug; 9(4):320-9. PubMed ID: 27418595
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of histopathological changes in patients with non-cirrhotic portal fibrosis.
Chougule A; Rastogi A; Maiwall R; Bihari C; Sood V; Sarin SK
Hepatol Int; 2018 Mar; 12(2):158-166. PubMed ID: 29651703
[TBL] [Abstract][Full Text] [Related]
16. Obliterative portal venopathy of the liver. Associated with so-called idiopathic portal hypertension or tropical splenomegaly.
Nayak NC; Ramalingaswami V
Arch Pathol; 1969 Apr; 87(4):359-69. PubMed ID: 5766763
[No Abstract] [Full Text] [Related]
17. Porto-sinusoidal vascular disorder.
De Gottardi A; Sempoux C; Berzigotti A
J Hepatol; 2022 Oct; 77(4):1124-1135. PubMed ID: 35690264
[TBL] [Abstract][Full Text] [Related]
18. Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.
Vilarinho S; Sari S; Yilmaz G; Stiegler AL; Boggon TJ; Jain D; Akyol G; Dalgic B; Günel M; Lifton RP
Hepatology; 2016 Jun; 63(6):1977-86. PubMed ID: 26874653
[TBL] [Abstract][Full Text] [Related]
19. Novel NPHS2 variant in patients with familial steroid-resistant nephrotic syndrome with early onset, slow progression and dominant inheritance pattern.
Suvanto M; Patrakka J; Jahnukainen T; Sjöström PM; Nuutinen M; Arikoski P; Kataja J; Kestilä M; Jalanko H
Clin Exp Nephrol; 2017 Aug; 21(4):677-684. PubMed ID: 27573339
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation in adult cystic fibrosis: Clinical, imaging, and pathological evidence of obliterative portal venopathy.
Hillaire S; Cazals-Hatem D; Bruno O; de Miranda S; Grenet D; Poté N; Soubrane O; Erlinger S; Lacaille F; Mellot F; Vilgrain V; Paradis V
Liver Transpl; 2017 Oct; 23(10):1342-1347. PubMed ID: 28816015
[No Abstract] [Full Text] [Related]
[Next] [New Search]
